Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
10/28/1999 | WO1999054436A2 Nucleic acids and proteins of c. elegans insulin-like genes and uses thereof |
10/28/1999 | WO1999054435A2 Immortalised cell lines derived from normal human skin tissues |
10/28/1999 | WO1999054359A1 Matrix binding factor |
10/28/1999 | WO1999054357A1 Novel cytokine-like protein |
10/28/1999 | WO1999054355A1 Process for the recovery and purification of a recombinant protein from a cell |
10/28/1999 | WO1999054353A2 Human nucleic acid sequences of normal uterus tissue |
10/28/1999 | WO1999054351A1 Edg family gene, human h218 |
10/28/1999 | WO1999054350A1 Novel omega conotoxin peptides |
10/28/1999 | WO1999054349A2 Dermatophagoides nucleic acid molecules, proteins and uses thereof |
10/28/1999 | WO1999054348A1 Rapidly degrading gfp-fusion proteins and methods of use |
10/28/1999 | WO1999054342A1 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity |
10/28/1999 | WO1999054341A1 Enhanced antisense modulation of icam-1 |
10/28/1999 | WO1999054340A1 Endotoxin reduction in nucleic acid purification |
10/28/1999 | WO1999053961A1 Peptides for efficient gene transfer |
10/28/1999 | WO1999053960A2 Enhancing immune responses to genetic immunization by using a chemokine |
10/28/1999 | WO1999053953A2 Methods and products related to metabolic interactions in disease |
10/28/1999 | WO1999053940A1 PNEUMOCOCCAL SURFACE PROTEIN C(PspC), EPITOPIC REGIONS AND STRAIN SELECTION THEREOF, AND USES THEREFOR |
10/28/1999 | WO1999053938A1 Isolated peptides corresponding to amino acid sequences of ny-eso-1, wherein bind to mhc class i and mhc class ii molecules, and uses thereof |
10/28/1999 | WO1999053927A1 Methods for treating and preventing insulin resistance and related disorders |
10/28/1999 | WO1999053762A1 A method for efficient and highly selective control of microorganisms |
10/28/1999 | WO1999053751A1 Source of nuclei for nuclear transfer |
10/28/1999 | WO1999045125A3 Methods and compositions for regulating cell death and enhancing disease resistance to plant pathogens |
10/28/1999 | WO1999043812A3 Dlc-1 gene, a putative tumors suppressor gene |
10/28/1999 | WO1999042839A3 Treating cancer |
10/28/1999 | WO1999042580A8 Gaba receptors and their uses |
10/28/1999 | WO1999042127A3 Receptor derived peptides as modulators of receptor activity |
10/28/1999 | WO1999041584A3 METHODS FOR PREDICTING PREGNANCY OUTCOME IN A SUBJECT BY hCG ASSAY |
10/28/1999 | WO1999041404A3 Novel means and methods for the preparation and activation of nucleoside and nucleotide based drugs |
10/28/1999 | WO1999041379A9 Members of the d52 gene family |
10/28/1999 | WO1999041378A9 Members of the d52 gene family |
10/28/1999 | WO1999040946A3 Methods and compositions for modulating leptin activity |
10/28/1999 | WO1999040112A9 Neuroprotective peptides and uses thereof |
10/28/1999 | WO1999039817A9 Method of quality control in manufacturing processes |
10/28/1999 | WO1999039740A3 Sensitizing cells to compounds using lipid-mediated gene and compound delivery |
10/28/1999 | WO1999038977A3 Plant having altered environmental stress tolerance |
10/28/1999 | WO1999037787A3 Human orthologues of wart |
10/28/1999 | WO1999037786A3 Methods and compositions for modifying levels of secondary metabolic compounds in plants |
10/28/1999 | WO1999037763A9 Novel nucleic acid molecules correlated with the rhesus weak d phenotype |
10/28/1999 | WO1999037299B1 Use of inhibitors for the treatment of disorders related to rtk hyperfunction, especially cancer |
10/28/1999 | WO1999035243A9 Extension of cellular lifespan, methods and reagents |
10/28/1999 | WO1999032516A3 Pharmaceutical compositions containing the long pentraxin ptx3 |
10/28/1999 | WO1999029898A3 Method for identifying nucleic acids by means of matrix-assisted laser desorption/ionisation mass spectrometry |
10/28/1999 | WO1999029341A3 Methods for enhancement of protective immume responses employing leishmania polypeptides |
10/28/1999 | WO1999028446A3 Branched chain amino acid biosynthetic enzymes |
10/28/1999 | WO1999027080A3 Human protein kinase and kinase inhibitors |
10/28/1999 | WO1999025724A3 Oligonucleotide synthesis using high boiling point solvents |
10/28/1999 | WO1999024463A3 Signal peptide-containing proteins |
10/28/1999 | WO1999005272A9 Use of transcription factor brn-3a |
10/28/1999 | WO1998044104A3 Flip gene and flip protein |
10/28/1999 | WO1998040099A9 Leptospira pathogens |
10/28/1999 | DE19818620A1 New polypeptides and their nucleic acids, useful for treatment of bladder tumor and identification of therapeutic agents |
10/28/1999 | DE19818619A1 New nucleic acid sequences expressed in bladder tumor tissue, and derived polypeptides, for treatment of bladder tumor and identification of therapeutic agents |
10/28/1999 | DE19817947A1 New nucleic acid sequences expressed in uterine myoma, and derived polypeptides, for treatment of uterine carcinoma and identification of therapeutic agents |
10/28/1999 | CA2658218A1 Improved immunodiagnostic assays using reducing agents |
10/28/1999 | CA2330839A1 Gene of rice dihydrodipicolinate synthase and dna relating to the same |
10/28/1999 | CA2328967A1 A method for efficient and highly selective control of microorganisms |
10/28/1999 | CA2328888A1 Rapidly degrading gfp-fusion proteins and methods of use |
10/28/1999 | CA2328463A1 Matrix binding factor |
10/28/1999 | CA2328399A1 Pneumococcal surface protein c(pspc), epitopic regions and strain selection thereof, and uses therefor |
10/28/1999 | CA2327800A1 Process for evaluating chemical and biological assays |
10/28/1999 | CA2326823A1 Nucleic acid molecules with novel chemical compositions capable of modulating gene expression |
10/28/1999 | CA2326689A1 Stress tolerant plants |
10/28/1999 | CA2326685A1 Enhancing immune responses to genetic immunization by using a chemokine |
10/28/1999 | CA2326670A1 Ikb and enhanced green fluorescent fusion protein |
10/28/1999 | CA2326623A1 Gene encoding syntaxin interacting protein |
10/28/1999 | CA2326498A1 Methods for reducing non-specific binding to a nucleic acid probe array |
10/28/1999 | CA2326384A1 Canine erythropoietin gene and recombinant protein |
10/28/1999 | CA2326067A1 Novel insecticidal toxins from xenorhabdus nematophilus and nucleic acid sequences coding therefor |
10/28/1999 | CA2325871A1 Human bile salt-stimulated lipase (bssl) obtainable from transgenic sheep |
10/28/1999 | CA2325864A1 Mutated peptide compounds, derived from hsp70, useful in cancer immunotherapy |
10/28/1999 | CA2325848A1 B-cell growth factor related protein |
10/28/1999 | CA2325822A1 Soluble protein ztmpo-1 |
10/28/1999 | CA2325821A1 Antisense oligonucleotides for the inhibition of integrin .alpha.v-subunit expression |
10/28/1999 | CA2325663A1 Novel mutations in the freac3 gene for diagnosis and prognosis of glaucoma and anterior segment dysgenesis |
10/28/1999 | CA2325604A1 Mutants of the mycobacterium species and the use thereof for screening for antibiotic vectors |
10/28/1999 | CA2325596A1 Combination therapy using nucleic acids and radio therapy |
10/28/1999 | CA2325573A1 A method for inhibiting tumor invasion or spreading in a subject |
10/28/1999 | CA2325561A1 Combination therapy using nucleic acids and conventional drugs |
10/28/1999 | CA2325391A1 Dermatophagoides nucleic acid molecules, proteins and uses thereof |
10/28/1999 | CA2325343A1 Quantitative analysis of gene expression |
10/28/1999 | CA2324995A1 Methods and products related to metabolic interactions in disease |
10/28/1999 | CA2324975A1 Isolated nucleic acid molecule encoding cancer associated antigens, the antigens per se, and uses thereof |
10/28/1999 | CA2324442A1 Polynucleotide sequences and their use in a method of producing plants with an increased number of stomata |
10/28/1999 | CA2324297A1 Sh2 domain-containing peptides |
10/28/1999 | CA2323571A1 Novel human k+ ion channel and therapeutic applications thereof |
10/28/1999 | CA2269103A1 Peptides binding to bone marrow stromal cell antigen |
10/27/1999 | EP0952224A2 Method for producing transgenic cucumber that produces high levels of superoxide dismutase |
10/27/1999 | EP0952223A1 REGULATORY SEQUENCE OF CELLULASE cbh1 GENES ORIGINATING IN TRICHODERMA VIRIDE AND SYSTEM FOR MASS-PRODUCING PROTEINS OR PEPTIDES THEREWITH |
10/27/1999 | EP0952222A1 Transgenic plants presenting a modified inulin producing profile |
10/27/1999 | EP0952221A2 L-Glutamic acid-producing bacterium and method for producing L-glutamic acid |
10/27/1999 | EP0952220A2 Method to predict active growth of bacteria adhered to a surface |
10/27/1999 | EP0952219A1 Recombinant proteins for the fusion of the porcine reproductive and respiratory syndrome virus and its use in diagnosis |
10/27/1999 | EP0952218A2 Single chain, multiple antigen-binding molecule, its preparation and use |
10/27/1999 | EP0952217A2 Use of a recombinant protein as receptor of a hepatitis virus |
10/27/1999 | EP0952216A2 Solid phase supports with PNA and amidate tag compliments |
10/27/1999 | EP0952214A1 Aviadenovirus |
10/27/1999 | EP0952158A1 Modified methylotrophic p. pastoris yeast which secretes human groth hormone |
10/27/1999 | EP0951911A2 Method for administering aspb28-human insulin |
10/27/1999 | EP0951910A2 Method for administering monomeric insulin analogs |
10/27/1999 | EP0951568A1 Methods for detecting and inhibiting the rna component of telomerase |